Karl G. Stonecipher

Jun 6, 2024 | eyetube.net | Karl G. Stonecipher |Neda Shamie

Machine Learning Models for the Diagnosis of Dry Eye Disease Karl G. Stonecipher, MD; and Neda Shamie, MD Show Description + Karl G. Stonecipher, MD, sits down with Neda Shamie, MD, to discuss the results of a study aimed at developing machine learning models for predicting the severity and type of dry eye disease using demographic and clinical data. What were the results? To access the full review, please visit the link here: https://www.touchophthalmology.com/?p=59842

Mar 10, 2024 | healio.com | Karl G. Stonecipher |Cassandra Jenkins |Christine Klimanskis

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024,Karl G. Stonecipher, MD, discusses newer treatments and thought processes in diagnostics in artificial intelligence in dry eye disease.

Dec 29, 2023 | eyetube.net | I. Paul Singh |Karl G. Stonecipher

Innovations in Premium IOLs: Small-Aperture Lenses I. Paul Singh, MD; and Karl G. Stonecipher, MD Show Description + Cataract/Refractive surgeon Karl Stonecipher, MD, joins I. Paul Singh, MD, for an in-depth discussion about the expanding options in the premium IOL category. The surgeons share their early experiences with small aperture IOLs and offer perspective on how they seek to match the right lens with the right patient. Innovations in Premium IOLs: Small-Aperture Lenses I.

Dec 6, 2023 | crstoday.com | Karl G. Stonecipher

Comparing wavefront-optimized and topography-guided ablation profiles. In the realm of astigmatism correction, wavefront-optimized (WFO) and topography-guided (TCAT) treatments offer distinct approaches to enhancing visual outcomes. This article contrasts these two techniques with an emphasis on their application in patients with normal corneas and astigmatism.

Feb 7, 2023 | healio.com | Karl G. Stonecipher |Christine Klimanskis

Source/Disclosures Disclosures: Stonecipher reports consulting for Allergan. We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Vuity has been available for more than a year, in which time we have learned a lot about this modality for treating presbyopia and honed our methods for selecting, screening and educating patients.